Si-Bone (SIBN) Cash & Current Investments (2017 - 2026)
Si-Bone's (SIBN) quarterly Cash & Current Investments came in at $144.7 million in Q1 2026, little changed year-on-year from $144.4 million in Q1 2025, and down 2.12% quarter-over-quarter from $147.8 million in Q4 2025.
Si-Bone (SIBN) Cash & Current Investments (2017 - 2026) Analysis & Trends
Si-Bone's Cash & Current Investments history runs 10 years deep, the most recent figure standing at $144.7 million for Q1 2026.
- On a quarterly basis, Cash & Current Investments changed 0.19% year-over-year to $144.7 million in Q1 2026; TTM through Mar 2026 was $144.7 million, a 0.19% change from a year earlier, with the FY2025 full-year figure at $147.8 million, down 1.48% from the prior year.
- Cash & Current Investments declined to $144.7 million in Q1 2026 per SIBN's latest filing, from $147.8 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $166.8 million in Q3 2023 and bottomed at $78.6 million in Q1 2023.
- The 5-year median for Cash & Current Investments is $145.7 million (2025), against an average of $134.7 million.
- Across the five-year window, Cash & Current Investments slumped 40.18% in 2022 and jumped 89.23% in 2024, its largest moves.
- Year by year, Cash & Current Investments stood at $84.6 million in 2022, then jumped by 84.55% to $156.1 million in 2023, then dropped by 3.87% to $150.0 million in 2024, then decreased by 1.48% to $147.8 million in 2025, then fell by 2.12% to $144.7 million in 2026.
- Per Business Quant, the three latest SIBN Cash & Current Investments figures stand at $144.7 million (Q1 2026), $147.8 million (Q4 2025), and $145.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Si-Bone | 753.03 Mn | 608.35 Mn | 41.94 Mn | 144.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 144.68 Mn |
| Dec 31, 2025 | 147.82 Mn |
| Sep 30, 2025 | 145.74 Mn |
| Jun 30, 2025 | 145.54 Mn |
| Mar 31, 2025 | 144.41 Mn |
| Dec 31, 2024 | 150.04 Mn |
| Sep 30, 2024 | 146.76 Mn |
| Jun 30, 2024 | 147.64 Mn |
| Mar 31, 2024 | 148.74 Mn |
| Dec 31, 2023 | 156.08 Mn |
| Sep 30, 2023 | 166.75 Mn |
| Jun 30, 2023 | 151.67 Mn |
| Mar 31, 2023 | 78.60 Mn |
| Dec 31, 2022 | 84.58 Mn |
| Sep 30, 2022 | 96.68 Mn |
| Jun 30, 2022 | 108.18 Mn |
| Mar 31, 2022 | 125.18 Mn |
| Dec 31, 2021 | 141.39 Mn |
| Sep 30, 2021 | 155.21 Mn |
| Jun 30, 2021 | 176.63 Mn |